Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan U Peled

Showing results (91-100 of 102) with videos related to

Pageof 11
Sort By:
Blood|January 29, 2021
Fecal microbiota diversity disruption and clinical outcomes after auto-HCT: a multicenter observational studyNiloufer Khan, Sarah Lindner, Antonio L C Gomes, et al.
Biorxiv : the Preprint Server for Biology|February 27, 2026
Differential effects of two common GVHD prophylaxis regimens on the gut microbiome: Results from the BMT CTN 1801 studyJakob Wirbel, Wael Saber, Michael J Martens, et al.
Science Translational Medicine|May 25, 2022
MAIT and Vδ2 unconventional T cells are supported by a diverse intestinal microbiome and correlate with favorable patient outcome after allogeneic HCTHana Andrlová, Oriana Miltiadous, Anastasia I Kousa, et al.
Nature Medicine|April 1, 2025
An inflammatory biomarker signature of response to CAR-T cell therapy in non-Hodgkin lymphomaSandeep S Raj, Teng Fei, Shalev Fried, et al.
Blood|May 21, 2020
The microbe-derived short-chain fatty acids butyrate and propionate are associated with protection from chronic GVHDKate A Markey, Jonas Schluter, Antonio L C Gomes, et al.
Science Translational Medicine|July 26, 2023
Tissue-specific features of the T cell repertoire after allogeneic hematopoietic cell transplantation in human and mouseSusan DeWolf, Yuval Elhanati, Katherine Nichols, et al.
Nature Medicine|March 15, 2022
Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapyMelody Smith, Anqi Dai, Guido Ghilardi, et al.
Nature Medicine|October 17, 2022
Author Correction: Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapyMelody Smith, Anqi Dai, Guido Ghilardi, et al.
Cancer Discovery|December 4, 2025
A High-Fiber Plant-Based Diet in Myeloma Precursor Disorders - Results from the NUTRIVENTION Clinical Trial and Preclinical Vk*MYC ModelUrvi A Shah, Laura Lucia Cogrossi, Juan-Jose Garces, et al.
The New England Journal of Medicine|February 27, 2020
Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell TransplantationJonathan U Peled, Antonio L C Gomes, Sean M Devlin, et al.
Pageof 11

Showing results (91-100 of 102) with videos related to

Sort By:
Pageof 11
Blood|January 29, 2021
Fecal microbiota diversity disruption and clinical outcomes after auto-HCT: a multicenter observational studyNiloufer Khan, Sarah Lindner, Antonio L C Gomes, et al.
Biorxiv : the Preprint Server for Biology|February 27, 2026
Differential effects of two common GVHD prophylaxis regimens on the gut microbiome: Results from the BMT CTN 1801 studyJakob Wirbel, Wael Saber, Michael J Martens, et al.
Science Translational Medicine|May 25, 2022
MAIT and Vδ2 unconventional T cells are supported by a diverse intestinal microbiome and correlate with favorable patient outcome after allogeneic HCTHana Andrlová, Oriana Miltiadous, Anastasia I Kousa, et al.
Nature Medicine|April 1, 2025
An inflammatory biomarker signature of response to CAR-T cell therapy in non-Hodgkin lymphomaSandeep S Raj, Teng Fei, Shalev Fried, et al.
Blood|May 21, 2020
The microbe-derived short-chain fatty acids butyrate and propionate are associated with protection from chronic GVHDKate A Markey, Jonas Schluter, Antonio L C Gomes, et al.
Science Translational Medicine|July 26, 2023
Tissue-specific features of the T cell repertoire after allogeneic hematopoietic cell transplantation in human and mouseSusan DeWolf, Yuval Elhanati, Katherine Nichols, et al.
Nature Medicine|March 15, 2022
Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapyMelody Smith, Anqi Dai, Guido Ghilardi, et al.
Nature Medicine|October 17, 2022
Author Correction: Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapyMelody Smith, Anqi Dai, Guido Ghilardi, et al.
Cancer Discovery|December 4, 2025
A High-Fiber Plant-Based Diet in Myeloma Precursor Disorders - Results from the NUTRIVENTION Clinical Trial and Preclinical Vk*MYC ModelUrvi A Shah, Laura Lucia Cogrossi, Juan-Jose Garces, et al.
The New England Journal of Medicine|February 27, 2020
Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell TransplantationJonathan U Peled, Antonio L C Gomes, Sean M Devlin, et al.
Pageof 11